23andMe CEO Considers Taking DNA Tester Private
The personalized DNA revolution falls short as a company's stock plummets by 90%. Valued at $3.5 billion, it seeks potential ...
- Latest
- Trending
The personalized DNA revolution falls short as a company's stock plummets by 90%. Valued at $3.5 billion, it seeks potential ...
Nelson Peltz's Trian Group is pushing for two board seats at Disney, citing lack of engagement and accountability. Peltz has ...
Netflix is a streaming stock worth considering over Disney+, with higher prices and a projected $6 billion free cash flow ...
NewRetirement, the financial planning startup, has secured Series A funding and plans to expand its enterprise partnerships and team amid ...
NBA EVP Chris Benyarko emphasizes integration and innovation in the league's projects, including the NBA App. The NBA aims to ...
Crocs shares surge over 12% after impressive Q4 results, beating expectations and receiving positive analyst ratings. The footwear brand's strong ...
Venture capital firm, Endiya Partners, plans to launch a $100-$125M fund to support digital startups in fields like AI, health, ...
Former ESPN president John Skipper revealed in an interview that Apple had previously attempted to create a joint sports media ...
Walgreens and CVS Health are two giants in the pharmacy and retail industry, but how do their strengths, weaknesses, opportunities, ...
In the battle of Netflix vs. traditional TV networks, we take a closer look at the strengths, weaknesses, opportunities, and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.